Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
Public ClinicalTrials.gov record NCT01365507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily in Insulin-naïve Subjects With Type 2 Diabetes Mellitus When Using Two Different Titration Algorithms (BOOST™: SIMPLE USE)
Study identification
- NCT ID
- NCT01365507
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Interventions
- insulin degludec/insulin aspart Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2011
- Primary completion
- Mar 31, 2012
- Completion
- Mar 31, 2012
- Last update posted
- Mar 16, 2017
2011 – 2012
United States locations
- U.S. sites
- 25
- U.S. states
- 11
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Concord | California | 94520-1926 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Montclair | California | 91763 | — |
| Novo Nordisk Investigational Site | Palm Springs | California | 92262 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32209-6511 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32258 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33027 | — |
| Novo Nordisk Investigational Site | Crestview Hills | Kentucky | 41017-3464 | — |
| Novo Nordisk Investigational Site | Madisonville | Kentucky | 42431 | — |
| Novo Nordisk Investigational Site | Paducah | Kentucky | 42003 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | North East | Maryland | 21901 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48235 | — |
| Novo Nordisk Investigational Site | Troy | Michigan | 48085-5524 | — |
| Novo Nordisk Investigational Site | Eagan | Minnesota | 55123 | — |
| Novo Nordisk Investigational Site | Smithtown | New York | 11787 | — |
| Novo Nordisk Investigational Site | Asheboro | North Carolina | 27203 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77070 | — |
| Novo Nordisk Investigational Site | Lubbock | Texas | 79423 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77478 | — |
| Novo Nordisk Investigational Site | Newport News | Virginia | 23606 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01365507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2017 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01365507 live on ClinicalTrials.gov.